Cerebral venous thrombosis: A typical presentation of COVID-19 in the young
- PMID: 32689590
- PMCID: PMC7245247
- DOI: 10.1016/j.jstrokecerebrovasdis.2020.104989
Cerebral venous thrombosis: A typical presentation of COVID-19 in the young
Abstract
Objective: Identify clinical and radiographic features of venous infarct as a presenting feature of COVID-19 in the young.
Background: SARS-CoV-2 infection causes hypercoagulability and inflammation leading to venous thrombotic events (VTE). Although elderly patients with comorbidities are at higher risk, COVID-19 may also cause VTE in a broader patient population without these risks. Neurologic complications and manifestations of COVID-19, including neuropathies, seizures, strokes and encephalopathy usually occur in severe established cases of COVID-19 infection who primarily present with respiratory distress.
Case description: Case report of a 29-year-old woman, with no significant past medical history or comorbidities, presenting with new onset seizures. Further questioning revealed a one-week history of headaches, low-grade fever, mild cough and shortness of breath, diagnosed as COVID-19. Imaging revealed a left temporoparietal hemorrhagic venous infarction with left transverse and sigmoid sinus thrombosis treated with full dose anticoagulation and antiepileptics.
Conclusion: Although elderly patients with comorbidities are considered highest risk for COVID-19 neurologic complications, usually when systemic symptoms are severe, this case report emphasizes that young individuals are at risk for VTE with neurologic complications even when systemic symptoms are mild, likely induced by COVID-19 associated hypercoagulable state.
Keywords: COVID-19; Cerebral venous thrombosis (CVT); Stroke in young; Venous thrombotic events (VTE).
Copyright © 2020 Elsevier Inc. All rights reserved.
Figures



Comment in
-
Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis.J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105222. doi: 10.1016/j.jstrokecerebrovasdis.2020.105222. Epub 2020 Aug 3. J Stroke Cerebrovasc Dis. 2020. PMID: 32891494 Free PMC article. No abstract available.
-
Author's response to Letter to the Editor: Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis.J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105227. doi: 10.1016/j.jstrokecerebrovasdis.2020.105227. Epub 2020 Jul 31. J Stroke Cerebrovasc Dis. 2020. PMID: 33020002 Free PMC article. No abstract available.
References
-
- Silvis SM, Sousa DAD, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555–565. - PubMed
-
- Field TS, Hill MD. Cerebral venous thrombosis. Stroke. 2019;50(6):1598–1604. - PubMed
-
- Mao L, Wang M, Chen S. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. SSRN Electron J. 2020:E1–E8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous